Israeli Health ministry approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children aged 5 to 11, two weeks after the U.S.
The Israeli Health ministry approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children aged 5 to 11, two weeks after the U.S. FDA grants its own approval, with vaccination expected to begin next week.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthIsraeli Health ministry approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children aged 5 to 11, two weeks after the U.S.
View Premium plansBrowse free archive reportsThe Israeli Health ministry approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children aged 5 to 11, two weeks after the U.S. FDA grants its own approval, with vaccination expected to begin next week.